Atlantic Lipid Lowering Treatment Optimization Program
Atlantic Lipid Lowering Treatment Optimization Program
Recruiting · NCT06439654 · Registry updated 2025-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atlantic Lipid Lowering Treatment Optimization Program | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hyperlipoproteinemia Type IIb, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, hyperlipidemia, hyperlipoproteinemia, hypoalphalipoproteinemia, hypolipoproteinemia, inborn errors of metabolism, metabolic disease | Recruiting | Not applicable | 2025-08-03 | NCT06439654 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atlantic Health System | 9 |
| Regeneron Pharmaceuticals | 238 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atlantic Medical Group | Clark | United States | 1 |
| Atlantic Medical Group | Springfield | United States | 1 |